Aktuelle Kardiologie 2015; 4(1): 28-36
DOI: 10.1055/s-0034-1396160
Übersichtsarbeit
Georg Thieme Verlag KG Stuttgart · New York

Ventrikelseptumdefekt

Ventricular Septal Defect
D. Id
Sankt Katharinen, CardioVasculäresCentrum, Frankfurt am Main
,
M. Hornung
Sankt Katharinen, CardioVasculäresCentrum, Frankfurt am Main
,
H. Sievert
Sankt Katharinen, CardioVasculäresCentrum, Frankfurt am Main
› Author Affiliations
Further Information

Publication History

Publication Date:
12 February 2015 (online)

Zusammenfassung

Ventrikelseptumdefekte sind die häufigsten aller kongenitalen Herzfehler und sind meist mit anderen kongenitalen Herzfehlern assoziiert. Aufgrund der unterschiedlichen Lage und Größe der Ventrikelseptumdefekte gibt es ein weites Spektrum klinischer Symptomatik und Therapieoptionen. Die Defekte liegen meist im perimembranösen Septumanteil, wobei die hämodynamische Auswirkung von der Defektgröße und dem pulmonalen Gefäßwiderstand abhängt. Kleine restriktive Ventrikelseptumdefekte ohne Symptomatik und hämodynamische Relevanz erfordern zunächst keine spezifische Therapie. Die frühzeitige Behandlung von mittleren und großen Ventrikelseptumdefekten mit großem Shuntvolumen verhindert das Auftreten von Komplikationen und sollte innerhalb des 1. Lebensjahrs erfolgen. Der interventionelle Defektverschluss kann bei perimembranösen oder muskulären Ventrikelseptumdefekten in Erwägung gezogen werden.

Abstract

Isolated ventricular septal defects are the most common congenital heart defects and are usually associated with other congenital cardiac malformations. Their clinical presentation and treatment vary greatly, because of different defect locations and sizes. Ventricular septal defects are mostly located in the perimembranous septum. The hemodynamic implication depends on the size of the defect and the pulmonary vascular resistance. Small restrictive ventricular septal defects without symptoms and hemodynamic relevance primarily require no specific therapy. Early treatment of medium and large sized ventricular septal defects with large shunt volume prevents complications and should be performed within the first year of life. Interventional defect closure should be considered in perimembranous and muscular ventricular septal defects.

 
  • Literatur

  • 1 Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222: 321-326
  • 2 Crenshaw BS, Granger CB, Birnbaum Y et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000; 101: 27-32
  • 3 Soto B, Becker AE, Moulaert AJ et al. Classification of ventricular septal defects. Br Heart J 1980; 43: 332-343
  • 4 Minette MS, Sahn DJ. Ventricular septal defects. Circulation 2006; 114: 2190-2197
  • 5 Kilner PJ, Geva T, Kaemmerer H et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010; 31: 794-805
  • 6 Krovetz LJ. Spontaneous closure of ventricular septal defect. Am J Cardiol 1998; 81: 100-101
  • 7 Soufflet V, Van de Bruaene A, Troost E et al. Behavior of unrepaired perimembranous ventricular septal defect in young adults. Am J Cardiol 2010; 105: 404-407
  • 8 Schmaltz AA, Bauer U, Baumgartner H et al. [Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society]. Clin Res Cardiol 2008; 97: 194-214
  • 9 Roos-Hesselink JW, Meijboom FJ, Spitaels SE et al. Outcome of patients after surgical closure of ventricular septal defect at young age: longitudinal follow-up of 22-34 years. Eur Heart J 2004; 25: 1057-1062
  • 10 Warnes CA, Williams RG, Bashore TM et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008; 118: e714-e833
  • 11 Tweddell JS, Pelech AN, Frommelt PC. Ventricular septal defect and aortic valve regurgitation: pathophysiology and indications for surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006; 147-152
  • 12 Scully BB, Morales DL, Zafar F et al. Current expectations for surgical repair of isolated ventricular septal defects. Ann Thorac Surg 2010; 89: 544-549 discussion 550–551
  • 13 Carminati M, Butera G, Chessa M et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J 2007; 28: 2361-2368
  • 14 Tzikas A, Ibrahim R, Velasco-Sanchez D et al. Transcatheter closure of perimembranous ventricular septal defect with the Amplatzer(®) membranous VSD occluder 2: initial world experience and one-year follow-up. Catheter Cardiovasc Interv 2014; 83: 571-580
  • 15 Chungsomprasong P, Durongpisitkul K, Vijarnsorn C et al. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil. Catheter Cardiovasc Interv 2011; 78: 1032-1040